Global & Disaster Medicine

Inovio Pharmaceuticals, Inc. and GeneOne Life Science, Inc. announced that they have received approval to initiate a phase I human trial to evaluate Inovio’s Zika DNA vaccine (GLS-5700)

Zika Vaccine


Comments are closed.

Categories

Recent Posts

Archives

Admin